Arcutis Biotherapeutics, Inc. Announced Findings From the Skin Insights: Uncovering Psoriasis Survey

IPC Corporate Member Arcutis Biotherapeutics, Inc. announced findings from the Skin Insights: Uncovering Psoriasis Survey, a national survey of 507 adults 18 and older diagnosed with plaque psoriasis that are on topical treatments. The online survey was designed to reveal insights into the emotional impact of the disease and challenges related to currently available topical treatments.

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Also Read

Boehringer Ingelheim

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

The United States Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) granted these designations based on the topline results from the EFFISAYIL™ 2 trial.

Monday, May 8, 2023

teledermatology

Opportunities and Limitations of Telemedicine in the Diagnosis and Treatment of Psoriasis

The patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is making it a priority.

Friday, April 21, 2023

Alexander Egeberg

Focus on Psoriasis: A Report from the 2023 American Academy of Dermatology (AAD) Annual Meeting

The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023, in New Orleans, LA, and is the largest dermatology meeting in the world, showcasing over 1,000 expert speakers and over 300 sessions. This report includes 13 summaries of talks focusing on psoriasis.

Thursday, March 30, 2023

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Arcutis Biotherapeutics, Inc. Announced Findings From the Skin Insights: Uncovering Psoriasis Survey

Leave a Reply Cancel reply

Categories

Recent Posts

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Also Read

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Opportunities and Limitations of Telemedicine in the Diagnosis and Treatment of Psoriasis

Focus on Psoriasis: A Report from the 2023 American Academy of Dermatology (AAD) Annual Meeting

Subscribe to the IPC Newsletter

Quick Links

Follow us